Likelihood ratios for fetal trisomy 21 based on nasal bone length in the second trimester: How best to define hypoplasia?

Ultrasound in Obstetrics and Gynecology

Volumn 30, Issue 3, 2007, Pages 271-274

  Cusick, W ^a   Shevell, T ^b   Duchan, L S ^a   Lupinacci, C A ^b   Terranova, J ^b   Crombleholme, W R ^b  

^a ST VINCENT S MEDICAL CENTER   (United States)

^b STAMFORD HOSPITAL   (United States)

Author keywords

Down syndrome; Likelihood ratios; Nasal bone

Indexed keywords

ARTICLE; BIPARIETAL DISTANCE; CONTROLLED STUDY; ECHOGRAPHY; FEMALE; FETUS; HUMAN; HYPOPLASIA; KARYOTYPE; NASAL BONE; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; RISK ASSESSMENT; SECOND TRIMESTER PREGNANCY; TRISOMY 21;

ADULT; DOWN SYNDROME; FEMALE; GESTATIONAL AGE; HUMANS; NASAL BONE; PREGNANCY; PREGNANCY TRIMESTER, SECOND; PROSPECTIVE STUDIES; RISK ASSESSMENT; ULTRASONOGRAPHY, PRENATAL;

EID: 34748874728     PISSN: 09607692     EISSN: 14690705     Source Type: Journal    
DOI: 10.1002/uog.4091     Document Type: Article

References (13)

1. Cicero S, Curcio P, Papageorghiou A, Sonek J, Nicolaides K. Absence of nasal bone in fetuses with trisomy 21 at 11-14 weeks of gestation: an observational study. Lancet 2001; 358: 1665-1667.
2. Cicero S, Bindra R, Rembouskos G, Tripsanas C, Nicolaides KH. Fetal nasal bone length in chromosomally normal and abnormal fetuses at 11-14 weeks of gestation. J Matern Fetal Neonatal Med 2002; 11: 400-402.
3. Otano L, Aiello H, Igarzabal L, Matayoshi T, Gadow EC. Association between first trimester absence of fetal nasal bone on ultrasound and Down syndrome. Prenat Diagn 2002; 22: 930-932.
4. Orlandi F, Bilardo CM, Campogrande M, Krantz D, Hallahan T, Rossi C, Viora E. Measurement of nasal bone length at 11-14 weeks of pregnancy and its potential role in Down syndrome risk assessment. Ultrasound Obstet Gynecol 2003; 22: 36-39.
5. Cusick W, Provenzano J, Sullivan CA, Gallousis FM, Rodis JF. Fetal nasal bone length in euploid and aneuploid fetuses between 11 and 20 weeks' gestation: a prospective study. J Ultrasound Med 2004; 23: 1327-1333.
6. Bromley B, Lieberman E, Shipp TD, Benacerraf BR. Fetal nasal bone length: a marker for Down syndrome in the second trimester. J Ultrasound Med 2002; 21: 1387-1394.
7. Viora E, Errante G, Sciarrone A, Bastonero S, Masturzo B, Martiny G, Campogrande M. Fetal nasal bone and trisomy 21 in the second trimester. Prenat Diagn 2005; 25: 511-515.
8. Vintzileos A, Walters C, Yeo L. Absent nasal bone in the prenatal detection of fetuses with trisomy 21 in a high-risk population. Obstet Gynecol 2003; 101: 905-908.
9. Odibo AO, Sehdev HM, Dunn L, McDonald R, Macones GA. The association between fetal nasal bone hypoplasia and aneuploidy. Obstet Gynecol 2004; 104: 1229-1233.
10. Cicero S, Sonek JD, McKenna DS, Croom CS, Johnson L, Nicolaides KH. Nasal bone hypoplasia in trisomy 21 at 15-22 weeks' gestation. Ultrasound Obstet Gynecol 2003; 21: 15-18.
11. Sonek JD, Nicolaides KH. Prenatal ultrasonographic diagnosis of nasal bone abnormalities in three fetuses with Down syndrome. Am J Obstet Gynecol 2002; 186: 139-141.
12. Cicero S, Bindra R, Rembouskos G, Spencer K, Nicolaides KH. Integrated ultrasound and biochemical screening for trisomy 21 using nuchal translucency, absent fetal nasal bone, free B-hCG and PAPP-A at 11 to 14 weeks. Prenat Diagn 2003; 23: 306-310.
13. Nicolaides KH. Editorial: Screening for chromosomal defects. Ultrasound Obstet Gynecol 2003; 21: 313-321.